CN112237605A - Medicine for treating fracture detumescence - Google Patents

Medicine for treating fracture detumescence Download PDF

Info

Publication number
CN112237605A
CN112237605A CN201910591743.3A CN201910591743A CN112237605A CN 112237605 A CN112237605 A CN 112237605A CN 201910591743 A CN201910591743 A CN 201910591743A CN 112237605 A CN112237605 A CN 112237605A
Authority
CN
China
Prior art keywords
parts
medicine
detumescence
fracture
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910591743.3A
Other languages
Chinese (zh)
Inventor
周凤臣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201910591743.3A priority Critical patent/CN112237605A/en
Publication of CN112237605A publication Critical patent/CN112237605A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/487—Psoralea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/744—Gardenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Husbandry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a medicine capable of quickly treating fracture and detumescence. The medicine comprises the components of Chinese angelica, cinnamon, frankincense, dipsacus root, szechuan lovage rhizome, peach seed, nux vomica, safflower, ground beetle, eucommia bark, myrrh, native copper, dragon's blood, gardenia, pearl, achyranthes bidentata, cassia twig, pseudo-ginseng, cinnabar, Chinese seasame, ephedra, borax, malaytea scurfpea fruit and borneol. The invention is mainly used for treating various pains of fracture, traumatic injury, sprain, contusion, trauma and the like. The finished product prepared by the invention is applied to the affected part, can quickly reduce swelling and relieve pain, and achieves the effect of strengthening tendons and bones. In addition, the invention has low manufacturing cost, convenient use and obvious quick healing effect, and is suitable for popularization and use in the related technical fields.

Description

Medicine for treating fracture detumescence
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a medicine capable of quickly treating fracture and detumescence.
Background
Fracture refers to a disease in which bone is partially or completely broken due to trauma or pathology. The main clinical manifestations are: local pain and tenderness of fracture, local swelling and ecchymosis, complete loss of functional parts of limbs, and deformity and abnormal movement of limbs due to complete bone.
In the prior art, Western medicine generally adopts a method for treating fracture to externally fix bones after reduction by using splints or plaster and supplement necessary internal and external medicine, so that patients suffer great pain and heal slowly. The fracture part usually needs to be fixed, so that the injured limb and the whole functional activity are limited; influence or destroy the intrinsic immobilization of the limb itself; reducing or damaging the natural repair capacity of the fracture; the physical pain and mental burden of the patient are increased, and the subjective initiative of the patient in the treatment is restrained.
Disclosure of Invention
The invention aims to solve the defects in the prior art and provides a medicine capable of quickly treating fracture and diminishing swelling.
The medicine comprises the components of Chinese angelica, cinnamon, frankincense, dipsacus root, szechuan lovage rhizome, peach seed, nux vomica, safflower, ground beetle, eucommia bark, myrrh, native copper, dragon's blood, gardenia, pearl, achyranthes bidentata, cassia twig, pseudo-ginseng, cinnabar, Chinese seasame, ephedra, borax, malaytea scurfpea fruit and borneol.
Preferably, the medicine comprises, by weight, 10-19 parts of angelica sinensis, 8-20 parts of cinnamon, 11-22 parts of frankincense, 9-17 parts of dipsacus root, 5-18 parts of ligusticum wallichii, 11-16 parts of peach kernel, 5-15 parts of semen strychni, 25-29 parts of safflower, 15-19 parts of ground beetle, 4-17 parts of eucommia ulmoides, 15-27 parts of myrrh, 10-30 parts of native copper, 2-6 parts of dragon's blood, 20-30 parts of gardenia jasminoides, 8-15 parts of pearl, 15-19 parts of achyranthes bidentata, 10-27 parts of cassia twig, 10-19 parts of pseudo-ginseng, 10-24 parts of cinnabar, 25-36 parts of fanghui, 8-19 parts of ephedra, 10-14 parts of borax, 15-21 parts of fructus psoraleae and 5-16 parts of borneol.
Preferably, the medicine comprises 12 parts of angelica, 12 parts of cinnamon, 15 parts of frankincense, 15 parts of dipsacus root, 12 parts of ligusticum wallichii, 12 parts of peach kernel, 10 parts of nux vomica, 25 parts of safflower, 15 parts of ground beetle, 15 parts of eucommia bark, 15 parts of myrrh, 20 parts of native copper, 5 parts of dragon's blood, 20 parts of gardenia jasminoides, 10 parts of pearl, 15 parts of achyranthes bidentata, 15 parts of cassia twig, 15 parts of pseudo-ginseng, 10 parts of cinnabar, 30 parts of Chinese seashore, 10 parts of ephedra, 10 parts of borax, 15 parts of fructus psoraleae and 10 parts of borneol.
Preferably, the medicinal components are proportioned according to the proportion and ground into powder.
Preferably, the medicament is ground into powder and then packaged for later use.
The invention relates to a medicine for quickly treating fracture and detumescence, which is mainly used for treating pains of various fractures, traumatic injuries, sprains, contusions, traumas and the like. The finished product prepared by the invention is applied to the affected part, can quickly reduce swelling and relieve pain, and achieves the effect of strengthening tendons and bones. In addition, the invention has low manufacturing cost, convenient use and obvious quick healing effect, and is suitable for popularization and use in the related technical fields.
Detailed Description
The present invention will now be described in more detail, wherein preferred embodiments of the invention are shown, it being understood that one skilled in the art may modify the invention herein described while still achieving the advantageous results of the invention. Accordingly, the following description should be construed as broadly as possible to those skilled in the art and not as limiting the invention.
In the interest of clarity, not all features of an actual implementation are described. In the following description, well-known functions or constructions are not described in detail since they would obscure the invention in unnecessary detail. It will of course be appreciated that in the development of any such actual embodiment, numerous implementation-specific details must be set forth in order to achieve the developer's specific goals, such as compliance with system-related and business-related constraints, which will vary from one implementation to another. Moreover, it will be appreciated that such a development effort might be complex and time-consuming, but would nevertheless be a routine undertaking for those of ordinary skill in the art.
The following description is provided to further illustrate the embodiments of the present invention, so that the objects and features of the present invention will be more clearly understood.
The first embodiment is as follows:
the medicine comprises 12 parts of angelica, 12 parts of cinnamon, 15 parts of frankincense, 15 parts of dipsacus root, 12 parts of ligusticum wallichii, 12 parts of peach kernel, 10 parts of nux vomica, 25 parts of safflower, 15 parts of ground beetle, 15 parts of eucommia bark, 15 parts of myrrh, 20 parts of native copper, 5 parts of dragon's blood, 20 parts of gardenia jasminoides, 10 parts of pearl, 15 parts of achyranthes bidentata, 15 parts of cassia twig, 15 parts of pseudo-ginseng, 10 parts of cinnabar, 30 parts of Chinese sea, 10 parts of ephedra, 10 parts of borax, 15 parts of fructus psoraleae and 10 parts of borneol.
Specifically, the medicinal components are proportioned according to a proportion and ground into powder. Then, bagging for standby.
Example two:
the medicine comprises the following components, by weight, 10 parts of angelica sinensis, 8 parts of cinnamon, 11 parts of frankincense, 9 parts of dipsacus root, 5 parts of ligusticum wallichii, 11 parts of peach kernel, 5 parts of semen strychni, 25 parts of safflower, 15 parts of ground beetle, 4 parts of eucommia bark, 15 parts of myrrh, 30 parts of native copper, 6 parts of dragon's blood, 30 parts of gardenia jasminoides, 15 parts of pearl, 19 parts of achyranthes bidentata, 27 parts of cassia twig, 19 parts of pseudo-ginseng, 24 parts of cinnabar, 36 parts of Chinese seas, 8 parts of ephedra, 10 parts of borax, 15 parts of fructus psoraleae and 16 parts of borneol.
Specifically, the medicinal components are proportioned according to a proportion and ground into powder. Then, bagging for standby.
Example three:
the medicine comprises 19 parts of angelica, 20 parts of cinnamon, 22 parts of frankincense, 17 parts of dipsacus root, 18 parts of ligusticum wallichii, 11 parts of peach kernel, 5 parts of nux vomica, 29 parts of safflower, 19 parts of ground beetle, 17 parts of eucommia bark, 27 parts of myrrh, 10 parts of native copper, 2 parts of dragon's blood, 20 parts of gardenia jasminoides, 15 parts of pearl, 15 parts of achyranthes bidentata, 10 parts of cassia twig, 19 parts of pseudo-ginseng, 10 parts of cinnabar, 36 parts of Chinese sea, 19 parts of ephedra, 10 parts of borax, 21 parts of fructus psoraleae and 16 parts of borneol.
Specifically, the medicinal components are proportioned according to a proportion and ground into powder. Then, bagging for standby.
The invention is mainly used for treating various pains of fracture, traumatic injury, sprain, contusion, trauma and the like. The finished product prepared by the invention is applied to the affected part, and can quickly reduce swelling and relieve pain; the finished product prepared by the invention is used for oral administration, and has the curative effect of strengthening tendons and bones. The invention has low manufacturing cost and obvious quick healing effect, and is suitable for popularization and use in the related technical field.
Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the embodiments. Thus, the present embodiments are not intended to be limited to the embodiments shown herein but are to be accorded the widest scope consistent with the principles and novel features disclosed herein.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the present invention, and any modifications, equivalents, improvements and the like made within the spirit and principle of the present invention shall be included in the scope of the present invention.

Claims (5)

1. A medicine for treating fracture and detumescence is characterized in that the medicine comprises the components of Chinese angelica, cinnamon, frankincense, dipsacus root, Szechuan lovage rhizome, peach seed, nux vomica, safflower, ground beetle, eucommia bark, myrrh, native copper, dragon's blood, gardenia jasminoides, pearl, achyranthes bidentata, cassia twig, pseudo-ginseng, cinnabar, cubic sea, ephedra, borax, malaytea scurfpea fruit and borneol.
2. The medicine for treating detumescence of bone fracture as claimed in claim 1, wherein the component ratios of the medicine include, 10-19 parts of angelica sinensis, 8-20 parts of cinnamon, 11-22 parts of frankincense, 9-17 parts of dipsacus root, 5-18 parts of ligusticum wallichii, 11-16 parts of peach kernel, 5-15 parts of nux vomica, 25-29 parts of safflower, 15-19 parts of ground beetle, 4-17 parts of eucommia bark, 15-27 parts of myrrh, 10-30 parts of native copper, 2-6 parts of dragon's blood, 20-30 parts of gardenia jasminoides ellis, 8-15 parts of pearl, 15-19 parts of achyranthes bidentata, 10-27 parts of cassia twig, 10-19 parts of pseudo-ginseng, 10-24 parts of cinnabar, 25-36 parts of Chinese sead, 8-19 parts of ephedra, 10-14 parts of borax, 15-21 parts of fructus psoraleae and 5-16 parts of borneol.
3. The medicine for treating fracture and detumescence as claimed in claim 2, wherein the medicine comprises, by weight, 12 parts of angelica sinensis, 12 parts of cinnamon, 15 parts of frankincense, 15 parts of dipsacus root, 12 parts of ligusticum wallichii, 12 parts of peach kernel, 10 parts of semen strychni, 25 parts of safflower, 15 parts of ground beetle, 15 parts of eucommia bark, 15 parts of myrrh, 20 parts of native copper, 5 parts of dragon's blood, 20 parts of gardenia jasminoides ellis, 10 parts of pearl, 15 parts of achyranthes bidentata, 15 parts of cassia twig, 15 parts of pseudo-ginseng, 10 parts of cinnabar, 30 parts of square sea, 10 parts of ephedra, 10 parts of borax, 15 parts of fructus psoraleae and 10 parts of borneol.
4. The medicine for treating fracture detumescence as claimed in claim 3, wherein the medicine components are proportionally mixed and ground into powder.
5. The medicine for treating swelling of bone fracture as claimed in claim 4, wherein the medicine is pulverized into powder and then packaged for use.
CN201910591743.3A 2019-07-01 2019-07-01 Medicine for treating fracture detumescence Pending CN112237605A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910591743.3A CN112237605A (en) 2019-07-01 2019-07-01 Medicine for treating fracture detumescence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910591743.3A CN112237605A (en) 2019-07-01 2019-07-01 Medicine for treating fracture detumescence

Publications (1)

Publication Number Publication Date
CN112237605A true CN112237605A (en) 2021-01-19

Family

ID=74175255

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910591743.3A Pending CN112237605A (en) 2019-07-01 2019-07-01 Medicine for treating fracture detumescence

Country Status (1)

Country Link
CN (1) CN112237605A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101019975A (en) * 2007-03-14 2007-08-22 吴方忠 Fracture treating Chinese medicine composition and its prepn

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101019975A (en) * 2007-03-14 2007-08-22 吴方忠 Fracture treating Chinese medicine composition and its prepn

Similar Documents

Publication Publication Date Title
CN101549102B (en) A bone fracture setting ointment and method for preparing same
CN101703757B (en) Plaster for reuniting fractured tendons and bones and activating blood, and preparation method thereof
CN100406052C (en) Chinese medicine for treating bone injury
CN101926867B (en) Bone fracture recovering soup
CN101607013B (en) Chinese medicament coaptation capsule and preparation method
CN103705700A (en) Topical lotion for promoting to heal bone fractures
CN112237605A (en) Medicine for treating fracture detumescence
CN106581343B (en) Konjac glucomannan medicinal bone-healing plaster and preparation method thereof
CN111643620A (en) Pure Chinese herbal medicine bonesetting medicine
CN103417944A (en) Swelling diminishing, blood activating and fracture healing ointment and method for manufacturing same
CN103127344B (en) The Chinese medicine preparation for the treatment of nonunion, the healing of fracture slowness and preparation method
CN103585257A (en) Traditional Chinese medicine powder for treating fractures
CN104224960A (en) Paste for lumbar osteoproliferation
CN110025675B (en) Traditional Chinese medicine spray for relieving swelling and pain and preparation method thereof
CN102247580A (en) Medicinal liquor for treating rheumatism, osteoproliferation and old injury
CN1267139C (en) Medicinal ointment for bone injury
CN114886949A (en) Ointment for treating arthralgia and preparation method thereof
KR101912200B1 (en) Detumescence odynolysis ointment
CN106038940A (en) External medicinal wine for treatment of fall injuries
KR101858897B1 (en) Detumescence odynolysis ointment
CN116808132A (en) Traditional Chinese medicine composition and application thereof
CN111494463A (en) Bone-knitting medicine
CN103239578B (en) Medicine for treating bone fractures
Abegunasekara et al. Therapeutic regimen for dislocations used by Traditional Ayurveda physicians in Sri Lanka
CN104107226A (en) Compound bone-joining tablet

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination